Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Sorrento Therapeutics revenue
Sorrento Therapeutics's revenue is $62.8 million.
What is Sorrento Therapeutics's revenue?
- Sorrento Therapeutics's revenue growth from 2010 to 2022 is 9,106.26%.
- Sorrento Therapeutics has 382 employees, and the revenue per employee ratio is $164,500.
- Sorrento Therapeutics's peak quarterly revenue was $121.9M in 2017(q3).
- Sorrento Therapeutics peak revenue was $151.9M in 2017.
- Sorrento Therapeutics annual revenue for 2021 was 52.9M, 32.31% growth from 2020.
- Sorrento Therapeutics annual revenue for 2022 was 62.8M, 18.78% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Sorrento Therapeutics historical revenue
Sorrento Therapeutics's peak revenue was $151.9M in 2017. The peak quarterly revenue was $121.9M in 2017(q3).
Sorrento Therapeutics's revenue increased from $682.6k in 2010 to $62.8M currently. That's a 9,106.26% change in annual revenue.
Sorrento Therapeutics annual revenue
Sorrento Therapeutics annual revenue over time
| Fiscal year / year | Sorrento Therapeutics revenue |
|---|---|
| 2010 | $682,568 |
| 2011 | $529,184 |
| 2012 | $584,000 |
| 2013 | $460,000 |
| 2014 | $3.8M |
| 2015 | $4.6M |
| 2016 | $8.2M |
| 2017 | $151.9M |
| 2018 | $21.2M |
| 2019 | $31.4M |
| 2020 | $40.0M |
| 2021 | $52.9M |
| 2022 | $62.8M |
How accurately did Sorrento Therapeutics' revenue projections match actual performance?
Sorrento Therapeutics annual growth
Sorrento Therapeutics saw the greatest revenue growth in 2017, when revenue increased by 1,762.81%.
Sorrento Therapeutics had the lowest revenue growth in 2018, when revenue changed by -86.04%.
Sorrento Therapeutics annual growth rate over time
| Year | Sorrento Therapeutics growth |
|---|---|
| 2011 | -22%↓ |
| 2012 | 10%↑ |
| 2013 | -21%↓ |
| 2014 | 732%↑ |
| 2015 | 20%↑ |
| 2016 | 78%↑ |
| 2017 | 1763%↑ |
| 2018 | -86%↓ |
| 2019 | 48%↑ |
| 2020 | 27%↑ |
| 2021 | 32%↑ |
| 2022 | 19%↑ |
Sorrento Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Sorrento Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2013 | $134,000 | $142,000 | $83,000 | $101,000 |
| 2014 | $976,000 | $775,000 | $1.3M | $798,000 |
| 2015 | $977,000 | $1.2M | $1.1M | $1.3M |
| 2016 | $988,000 | $902,000 | $2.2M | $4.0M |
| 2017 | $4.9M | $4.7M | $121.9M | $20.4M |
| 2018 | $6.2M | $3.9M | $4.1M | $6.9M |
| 2019 | $6.1M | $6.5M | $5.8M | $13.0M |
| 2020 | $7.7M | $9.0M | $11.8M | $11.5M |
| 2021 | $14.3M | $13.5M | $12.1M | $13.1M |
| 2022 | $18.4M | $11.5M | $17.4M | $15.6M |
| 2023 | $16.3M | $15.0M | - | - |
Sorrento Therapeutics jobs nearby
Do you work at Sorrento Therapeutics?
Is Sorrento Therapeutics transparent about its revenue structure?
Sorrento Therapeutics financial information
| CEO | Henry H. Ji |
| Company Type | Public |
| Employees Number | 382 |
| Date Founded | 2006 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $62.8M |
| Net Income | -$572,843,000 |
| Gross Proft | $29.4M (2022) |
| EBITDA | ($562.4M) (2022) |
| PE Ratio | -0.44 |
| Tax Rate | 0.0% |
| Market Capitalization | $253.1M |
| Total Assets | $472,840,000 |
| Ticker | SRNE |
Sorrento Therapeutics jobs you might like
Sorrento Therapeutics financing
Sorrento Therapeutics received early financing of $2.3M on 2009-06-19.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $2.3M | 06/2009 |
| Post Ipo Equity | $2M | 01/2012 |
| Post Ipo Equity | $6.4M | 03/2013 |
| Post Ipo Debt | $1.9M | 10/2013 |
| Debt Financing | $1.9M | 10/2013 |
| Post Ipo Equity | $150M | 04/2016 |
| Post Ipo Debt | $75M | 11/2016 |
| Post Ipo Equity | $25M | 10/2019 |
Sorrento Therapeutics investors
| Investors | Security type |
|---|---|
| Ally Bridge Group | Post Ipo Equity |
Search for jobs
Sorrento Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Sorrento Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sorrento Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sorrento Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sorrento Therapeutics. The data presented on this page does not represent the view of Sorrento Therapeutics and its employees or that of Zippia.
Sorrento Therapeutics may also be known as or be related to SORRENTO THERAPEUTICS INC., Sorrento Therapeutics, Sorrento Therapeutics Inc and Sorrento Therapeutics, Inc.